City of Hope scientists have combined a checkpoint inhibitor with an anti-parasitic drug, ivermectin, to successfully treat triple-negative breast cancer in preclinical research, according to a study published March 2...

City of Hope scientists have identified an unlikely way to potentially prevent or slow the progression of aggressive breast cancer: target one’s internal clock.   Often taken for granted, the...

Scientists at City of Hope, working in collaboration with researchers at Translational Genomics Research Institute (TGen), have found that the actions of circulating immune cells at the start of immunotherapy...

Ajay Goel, Ph.D., M.S.For years, surgeons have operated on pancreatic cancer patients to remove what they thought was a localized tumor only to discover that the disease had spread...

Researchers at City of Hope have developed a tool that could predict if older adults with early-stage breast cancer will develop a severe or deadly reaction to chemotherapy.   This...

At a recent virtual symposium — “Diabetes and Cancer Interface: Connecting the Dots” — City of Hope gynecologic cancer expert Lorna Rodríguez-Rodriguez, M.D., Ph.D., issued a call to arms of...

City of Hope has identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published in...

City of Hope scientists are studying how diverse populations have different risk factors for and are affected differently by prostate, lung, skin, breast, colon and other cancers, as well as...

City of Hope scientists have combined two potent immunotherapies — an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy — to target and eradicate solid tumors that are...

Cancer care is changing rapidly, and the pace of change is accelerating. In 2019, major advances in precision medicine, gene-based therapy, immunotherapy and many other areas brought new hope to...